Navigation Links
Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
Date:11/11/2008

is platform technology, which has produced novel anti-cancer drug candidates that overcome the limitations of current treatments," said Mr. Stonebanks. "Our drug candidates have been shown to not only inhibit the growth and spread of tumors, but also significantly enhance survival in preclinical studies. I look forward to working with Chief Operating Officer Richard Purcell and our outstanding team to advance these promising compounds with the goal of advancing our first product candidate into the clinic during 2009."

Prior to joining Cynvec, Mr. Stonebanks led the global healthcare & life science mergers and acquisitions efforts at IBM, advising the company on its healthcare and life science strategy. He was previously Vice President and General Manager at Johnson & Johnson where he co-founded and ran The Macroflux(R) Corporation, a private drug delivery company spun out from Johnson & Johnson in October 2006 through a $100 million deal funded by a syndicate of venture and private equity investors. Before J&J, Mr. Stonebanks founded and served as executive director and leader of the Oncology Biologics Business Unit at Centocor, a unit in the Global Marketing group that integrated marketing, medical affairs, market research and health outcomes.

Mr. Stonebanks completed his undergraduate degree in Exercise Physiology at the University of Victoria, B.C., Canada and his MBA in Pharmaceutical Marketing at St. Joseph's University in Philadelphia.

About Cynvec LLC

Cynvec was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as standalone oncolytic therapeutics, delivery systems for monoclonal antibodies and cytokines as well as cancer diagnostic products. The Sindbis vector system, originally developed at NYU School of Medicine, represents a unique, patented platform technology for numerous commercial applications. The company is developing therapi
'/>"/>

SOURCE Cynvec LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
2. NutraCea Appoints New Chief Financial Officer
3. Cardiac Science Appoints Dave Marver as Chief Operating Officer
4. Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
5. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
6. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
7. Nikon Instruments Appoints LABSCO its Clinical Distributor in Six States
8. China Pharma Holdings, Inc. Appoints The Ruth Group
9. Althea Technologies Appoints Dr. Shabbir Anik as Chief Executive Officer
10. GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)
11. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), a ... address unmet medical needs in women,s health, today ... present at the Cantor Fitzgerald Inaugural Healthcare Conference ... 4:45 PM EDTLocation: , Le Parker Meridien Hotel, ... www.juniperpharma.com, under  ,Investor, or  click here ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... filter that does not sacrifice selectivity to achieve faster flow rates in comparison ... fine pores with significant open space to allow easy liquid flow while trapping ...
(Date:6/30/2015)... ... ... Matrix Marketing Group, LLC , a leading provider of performance-based marketing services ... account management department as vice president of client services. Amanda Gregory joins the ... delivery expertise to the growing Matrix Marketing Group team in Denver, Colorado. , ...
(Date:6/30/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... on the development of autologous cell therapies, announced today ... clinical trial of RCT-01, being tested for the ... enrolled and their tissue biopsy sent for processing ... of non-bulbar dermal sheath (NBDS) cells isolated from ...
Breaking Biology Technology:Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Matrix Marketing Group Expands Client Services Team 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... 5 The American Society of,Hematology (ASH) will ... the,Georgia World Congress Center on Friday, December 7, ... encourages an interest in hematology,the biological sciences, and ... 49th Annual Meeting. This year, students will have ...
... will issue its fourth quarter and fiscal year,2007 financial results on December 11, 2007. ... to discuss the results., December 11, 2007 Schedule:, After ... ... distributed by PR Newswire 4:20 p.m. EST ...
... Transformation Initiative to Generate Pre-Tax Cost, Savings and Avoidance of Approximately $1.5 Billion ... Total ... 10%, * Announces 11% Increase in Indicative Dividend for 2008 and Declares ... Quarterly Dividend, * Revises 2007 ...
Cached Biology Technology:ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007 2Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007 3Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 2Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 3Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 4Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 5Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 6Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 7Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 8Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 9Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 10Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 11
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... , June 17, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Xiaomi, one of the ... ® ClearPad ® family of capacitive ... integrated circuits (DDICs) for its latest smartphones, the ... ClearPad for full in-cell display solutions and DDICs ...
(Date:6/16/2015)... Sweden , June 16, 2015 ... all touch fingerprint sensors in the company,s portfolio from one ... Deliveries are planned to mainly take place during the third ... in Asia . Jörgen Lantto, ... evidence of    the   growing interest from smartphone OEMs ...
Breaking Biology News(10 mins):Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2
... new study by Rebecca Baggaley, Neil Ferguson, and Geoff ... epidemic in poor countries will not be controlled through ... As they demonstrate in an article in the open-access ... such as counseling patients and their communities about safe ...
... causes mice to develop the metabolic syndrome, researchers at ... at OHSU, the University of Texas Medical Branch and ... lack the gene encoding the DNA repair enzyme NEIL1 ... twice the weight of their normal counterparts. The mice, ...
... advance research into new drugs for the treatment of ... Center's research will be headed by one of the ... Research Alliance Eminent Scholar in Computational Systems Biology. , ... of Georgia, the Georgia Research Alliance and the National ...
Cached Biology News:Access to antiretrovirals unlikely to reduce HIV infection rates 2Removing DNA repair gene causes metabolic syndrome 2Removing DNA repair gene causes metabolic syndrome 3Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 2Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 3Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 4
... Kit, For 100 slides. Immunocytochemistry.Sample types: ... vitro tissue labeling.Recommended cell number: ... 1-2 hours).Store at 2-8 C (except ... Drug Screening & Cellular Assays, Assays ...
... Ideal for isolation and affinity purification ... and peptides. Hydrophobic, monodisperse magnetic particles ... (tosyl) groups, further surface activation is ... antibodies with optimal orientation for affinity ...
... Anti-phospho-Ser/Thr-Pro, MPM-2, agarose conjugate ... sodium azide Quality ... immunoprecipitating mitotic MPM2 antigens ... HeLa cells as shown ...
Calcium Channel alpha 2 delta-2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone 42, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: